FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+13.78%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.67B
AUM Growth
+$1.67B
(+11%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-1.09%
Top 10 Holdings %
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5
Top Buys
| 1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$26.3M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$18.5M |
| 3 |
Alphatec Holdings
ATEC
|
$15.4M |
| 4 |
Relay Therapeutics
RLAY
|
$14.3M |
| 5 |
Insmed
INSM
|
$12.4M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$51.8M |
| 2 |
CareDx
CDNA
|
$29M |
| 3 |
BioXcel Therapeutics
BTAI
|
$15.5M |
| 4 |
Maravai LifeSciences
MRVI
|
$12.1M |
| 5 |
Health Catalyst
HCAT
|
$11.5M |
Sector Composition
| 1 | Healthcare | 83.7% |
| 2 | Communication Services | 4.44% |
| 3 | Energy | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Pfizer
PFE
$141B
| $332K | 0.02% |
8,469
| – | – |
|
77
Universal Health Services
UHS
$11.6B
| $300K | 0.02% |
2,050
| – | – |
|
78
Emergent Biosolutions
EBS
$418M
| $270K | 0.02% |
4,294
| – | – |
|
79
McKesson
MCK
$85.9B
| $257K | 0.02% |
1,346
| – | – |
|
80
Zymeworks
ZYME
$1.07B
| – | – |
-117,848
| Closed | -$3.72M |
|
81
Quanterix
QTRX
$202M
| – | – |
-27,100
| Closed | -$1.59M |
|
82
908 Devices
MASS
$199M
| – | – |
-20,700
| Closed | -$1M |
|
83
Jazz Pharmaceuticals
JAZZ
$7.99B
| – | – |
-53,484
| Closed | -$8.79M |
|
|
84
BioXcel Therapeutics
BTAI
$52.7M
| – | – |
-358,439
| Closed | -$15.5M |
|